Fu Qiang, Du Chao, Gong Chuan-yong, Wang Na
Tianjin Medical University, Tianjin, China.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012 Aug;24(8):461-4.
To evaluate the influence of serum estradiol, prolactin and testosterone levels on human leukocyte antigen-DR (HLA-DR), soluble myeloid cell receptor-1 (sTREM-1) and prognosis in patients with severe abdominal infection, in order to evaluate the clinical value of the above-mentioned sex hormones.
From July 10, 2009 to February 9, 2010, 73 cases with severe intra-abdominal infections hospitalized in surgical intensive care unit (ICU) of Tianjin Nankai Hospital were enrolled. Within 72 hours after enrollment, serum estradiol, prolactin and testosterone levels were detected by radioimmunoassay. Based on their levels, all the cases were divided into increased estradiol group (n=38) and non-increased estradiol group (n=35), increased prolactin group (n=28) and non-increased prolactin group (n=45), decreased testosterone group (n=33) and non-decreased testosterone group (n=40) respectively. In addition, HLA-DR (flow cytometry), as well as of sTREM-1 (enzyme linked immunosorbent assay), acute physiology and chronic health evaluation II (APACHEII) score, hospital days, the ICU length, hospital costs and 28 day mortality were recorded.
Compared with non-increased estradiol group, HLA-DR in increased estradiol group decreased significantly [(61.22±22.39)% vs. (75.09±14.85)%], while sTREM-1 (ng/L) increased obviously (291.59±148.13 vs. 216.48±124.82), APACHEII score lowered dramatically (11.47±6.88 vs. 15.36±8.79), hospital costs (ten thousands) raised significantly (10.98±8.15 vs 6.25±3.51), ICU length (days) was much shorter (8.56±4.05 vs. 12.17±7.99), and 28 days mortality was significantly lowered (10.00% vs. 32.75%,P<0.05 or P<0.01). Compared with non-increased prolactin group, increased prolactin group had much lower HLA-DR levels [(61.19±21.50)% vs. (72.02±18.49)%], higher sTREM-1 levels (307.92±173.93 vs. 223.01±106.93), at the same time, their cost of hospitalization (7.75±3.52 vs. 11.36±8.24) and ICU stay length (9.14±3.15 vs. 13.24±2.16) were significantly lower (all P<0.05). Compared with non-decreased testosterone group, HLA-DR in decreased testosterone group increased significantly [(74.69±14.72)% vs. (62.24±22.54)%], while sTREM-1 decreased obviously (208.77±77.80 vs. 294.20±169.36), APACHEII score lowered dramatically (10.57±6.97 vs. 15.39±9.46), hospital costs decreased significantly (7.67±3.81 vs. 11.19±8.05), and 28 days mortality lowered significantly (0 vs. 30.14%, P<0.05 or P<0.01).
In the early stage of severe intra-abdominal infection, estrogen, prolactin and testosterone levels had powerful influences on immune, inflammation, and prognosis, which may indicated a widespread clinical application.
评估血清雌二醇、催乳素和睾酮水平对严重腹部感染患者人类白细胞抗原-DR(HLA-DR)、可溶性髓系细胞触发受体-1(sTREM-1)及预后的影响,以评价上述性激素的临床价值。
选取2009年7月10日至2010年2月9日在天津市南开医院外科重症监护病房(ICU)住院的73例严重腹腔内感染患者。入选后72小时内,采用放射免疫法检测血清雌二醇、催乳素和睾酮水平。根据检测结果,将所有患者分别分为雌二醇升高组(n=38)和雌二醇未升高组(n=35)、催乳素升高组(n=28)和催乳素未升高组(n=45)、睾酮降低组(n=33)和睾酮未降低组(n=40)。此外,记录HLA-DR(流式细胞术)、sTREM-1(酶联免疫吸附测定)、急性生理与慢性健康状况评分II(APACHEII)、住院天数、ICU住院时间、住院费用及28天死亡率。
与雌二醇未升高组相比,雌二醇升高组HLA-DR显著降低[(61.22±22.39)% vs.(75.09±14.85)%],而sTREM-1(ng/L)明显升高(291.59±148.13 vs. 216.48±124.82),APACHEII评分显著降低(11.47±6.88 vs. 15.36±8.79),住院费用(万元)显著升高(10.98±8.15 vs 6.25±3.51),ICU住院时间(天)明显缩短(8.56±4.05 vs. 12.17±7.99),28天死亡率显著降低(10.00% vs. 32.75%,P<0.05或P<0.01)。与催乳素未升高组相比,催乳素升高组HLA-DR水平更低[(61.19±21.50)% vs.(72.02±18.49)%],sTREM-1水平更高(307.92±173.93 vs. 223.01±106.93),同时其住院费用(7.75±3.52 vs. 11.36±8.24)和ICU住院时间(9.14±3.15 vs. 13.24±2.16)显著更低(均P<0.05)。与睾酮未降低组相比,睾酮降低组HLA-DR显著升高[(74.69±14.72)% vs.(62.24±22.54)%],而sTREM-1明显降低(208.77±77.80 vs. 294.20±169.36),APACHEII评分显著降低(10.57±6.97 vs. 15.39±9.46),住院费用显著降低(7.67±3.81 vs. 11.19±8.05),28天死亡率显著降低(0 vs. 30.14%,P<0.05或P<0.01)。
在严重腹腔内感染早期,雌激素、催乳素和睾酮水平对免疫、炎症及预后有显著影响,可能具有广泛的临床应用价值。